<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id>
<journal-title>Frontiers in Pediatrics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pediatr.</abbrev-journal-title>
<issn pub-type="epub">2296-2360</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fped.2021.762241</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pediatrics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Preoperative Hemoglobin Level, Oxygen Saturation and Postoperative Outcomes in Children With Cyanotic Congenital Heart Disease: A Propensity-Score Matching Analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zhou</surname> <given-names>Dan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Deng</surname> <given-names>Li-Jing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ling</surname> <given-names>Yun-Fei</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Tang</surname> <given-names>Meng-Lin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1448007/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Pediatric Intensive Care Unit, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>West China School of Nursing, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Cardiac Surgery, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Luca Filippi, University of Pisa, Italy</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: John S. Kim, University of Colorado, United States; Mingyi Zhao, Central South University, China</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Meng-Lin Tang <email>menglin_tang&#x00040;163.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Pediatric Critical Care, a section of the journal Frontiers in Pediatrics</p></fn></author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>762241</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>12</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Zhou, Deng, Ling and Tang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhou, Deng, Ling and Tang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<abstract>
<sec>
<title>Background</title>
<p>The optimal preoperative hemoglobin (Hb) level is difficult to define in children with cyanotic congenital heart disease (CHD) due to hypoxemia-induced secondary erythrocytosis. This retrospective study integrated preoperative Hb and pulse oxygen saturation (SpO<sub>2</sub>) using the product of Hb &#x000D7; SpO<sub>2</sub> to predict postoperative outcomes in children with cyanotic CHD.</p></sec>
<sec>
<title>Patients and Methods</title>
<p>Children aged &#x0003C;18 years undergoing cardiac surgery with cyanotic CHD were included. The cutoff value of Hb &#x000D7; SpO<sub>2</sub> was the age-adjusted lower limit of normal Hb (aaHb) in healthy children. The main outcomes were in-hospital death and the composite outcome of severe postoperative events. Multivariate logistic regression analysis and propensity score matching analysis were used to adjust for important confounders.</p></sec>
<sec>
<title>Results</title>
<p>The presence of preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb was observed in 21.6% of cyanotic children (<italic>n</italic> = 777). Children with Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb had higher in-hospital mortality (12.5% vs. 4.6%, <italic>P</italic> &#x0003C; 0.001) and composite outcome incidence (69.6% vs. 32.3%, <italic>P</italic> &#x0003C; 0.001) than those with Hb &#x000D7; SpO<sub>2</sub> &#x02265; aaHb. After propensity score matching, 141 pairs of children were successfully matched. Multivariate analysis showed that preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb was significantly associated with the composite outcome in the entire population (odds ratio = 4.092, 95% confidence interval = 2.748&#x02013;6.095, <italic>P</italic> &#x0003C; 0.001) and the matched cohorts (odds ratio = 2.277, 95% confidence interval = 1.366&#x02013;3.795, <italic>P</italic> = 0.002).</p></sec>
<sec>
<title>Conclusion</title>
<p>Our results suggest that a preoperative Hb &#x000D7; SpO<sub>2</sub> value below the lower limit of normal hemoglobin is a prognostic factor in cyanotic children undergoing cardiac surgery and is a potential criterion to evaluate preoperative anemia in this population.</p></sec></abstract>
<kwd-group>
<kwd>children</kwd>
<kwd>cyanosis</kwd>
<kwd>hemoglobin</kwd>
<kwd>oxygen saturation</kwd>
<kwd>congenital heart disease</kwd>
<kwd>outcome</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="3"/>
<equation-count count="4"/>
<ref-count count="35"/>
<page-count count="9"/>
<word-count count="5978"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Anemia is a common disease in pediatrics, presenting in 15&#x02013;74% of this population (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B6">6</xref>). A reduction in oxygen-carrying capacity can lead to inadequate tissue oxygenation and organ function (<xref ref-type="bibr" rid="B7">7</xref>). As a result, anemia may impair the body&#x00027;s resistance to surgical stress. Recent studies indicate that preoperative anemia is associated with higher in-hospital mortality in children undergoing noncardiac surgery (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>), but little is known about this association in children undergoing cardiac surgery. Limited evidence has shown that preoperative hemoglobin (Hb) &#x0003C;11.0 g/dl is associated with a higher risk of postoperative acute kidney injury in children with congenital heart disease (CHD) (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>CHD can be divided into two categories according to the presence or absence of cyanosis (<xref ref-type="bibr" rid="B9">9</xref>&#x02013;<xref ref-type="bibr" rid="B11">11</xref>). Cyanosis and hypoxemia may occur if a significant right-to-left shunt exists in a heart defect, and generally, these are defects with significant complexity (<xref ref-type="bibr" rid="B10">10</xref>). Cyanosis can increase early and late postoperative mortality in children undergoing cardiac surgery (<xref ref-type="bibr" rid="B9">9</xref>) and enhance the long-term risks of noncardiac surgery and type 2 diabetes mellitus in adulthood (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Although cyanotic CHD is more complex and associated with poor clinical outcomes, cyanotic patients were excluded in some anemia-related studies (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). The main obstacle is that the optimal Hb level is difficult in cyanotic patients when hypoxemia leads to secondary erythrocytosis and an increase in the Hb concentration (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>The main function of hemoglobin is to transport oxygen. Under normal nutritional and hematopoietic conditions, there is an inverse relationship between the severity of compensatory erythrocytosis and resting oxygen saturation in cyanotic patients (<xref ref-type="bibr" rid="B14">14</xref>). Therefore, this study integrated preoperative Hb and oxygen saturation to predict postoperative outcomes in children with cyanotic CHD.</p>
</sec>
<sec id="s2">
<title>Patient and Methods</title>
<sec>
<title>Patient Population and Data Collection</title>
<p>This retrospective study was conducted in a university-affiliated tertiary hospital using data from December 2008 to December 2018. Children were included if (1) they were younger than 18 years; (2) their diagnosis was CHD; (3) their heart defects led to right-to-left shunts, cyanosis and hypoxemia (resting SpO<sub>2</sub>  &#x02264;  90%); and (4) they underwent open heart surgery. Children were excluded if (1) their preoperative Hb and resting SpO<sub>2</sub> were unavailable; (2) they had preoperative invasive or noninvasive mechanical ventilation; (3) they received preoperative blood transfusion; or (4) they had diseases that resulted in abnormal Hb quality, such as thalassemia and carbon monoxide poisoning.</p>
</sec>
<sec>
<title>Data Collection and Definition</title>
<p>The following clinical data were collected: age, sex, disease history, altitude of long-term residence, clubbed fingers or toes, preoperative comorbidities, routine blood analysis results, resting SpO<sub>2</sub>, echocardiographic record, type of heart defect, Risk Adjustment for Congenital Heart Surgery 1 (RACHS-1) score (<xref ref-type="bibr" rid="B15">15</xref>), duration of invasive mechanical ventilation, and postoperative adverse events. Preoperative comorbidities within 1 month prior to surgery included abnormal liver and kidney function, stroke, thyroid disease, respiratory disease, heart disease and infection. The resting SpO<sub>2</sub> data without oxygen therapy within 2 weeks prior to surgery measured by the noninvasive pulse oximeter were recorded, and the average SpO<sub>2</sub> was calculated for children with multiple measurements of different fingers and toes. Echocardiographic data included left ventricular ejection fraction, pulmonary arterial hypertension, patent ductus arteriosus and aortopulmonary collateral arteries. For patients with a single ventricle, the ejection fraction of the single ventricle was recorded.</p>
<p>Postoperative children were followed up until discharge or in-hospital death. A severe adverse event is any unfortunate occurrence that either results in death or a life-threatening event prolonging the length of hospital stay (<xref ref-type="bibr" rid="B16">16</xref>), including in-hospital death, cardiac arrest, sepsis, reoperation, severe hemorrhage, and the duration of invasive mechanical ventilation in 75&#x02013;100th percentile. The main outcomes were in-hospital death and the composite of severe postoperative adverse events. Sepsis in this study refers to conditions previously termed <italic>severe sepsis</italic> in the international pediatric sepsis consensus (<xref ref-type="bibr" rid="B17">17</xref>). Severe hemorrhage included intracranial hemorrhage, acute bleeding-induced hemodynamic instability and a 20% decrease in Hb levels.</p>
</sec>
<sec>
<title>Mathematical Model for Integrating Hemoglobin and Oxygen Saturation</title>
<p>Physically dissolved oxygen is rare, and noninvasive SpO<sub>2</sub> could replace invasive arterial oxygen saturation (SaO<sub>2</sub>) tests (<xref ref-type="bibr" rid="B18">18</xref>), so the arterial oxygen content (CaO<sub>2</sub>) for blood with normal Hb quality could be estimated according to the formula:</p>
<disp-formula id="E1"><mml:math id="M1"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mtext>Ca</mml:mtext><mml:msub><mml:mrow><mml:mtext>O</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mtext>ml</mml:mtext><mml:mo>/</mml:mo><mml:mtext>dl</mml:mtext></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo><mml:mn>39</mml:mn><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mtext>ml</mml:mtext><mml:mo>/</mml:mo><mml:mtext>g</mml:mtext></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>&#x000D7;</mml:mo><mml:mtext>Hb</mml:mtext><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mtext>g</mml:mtext><mml:mo>/</mml:mo><mml:mtext>dl</mml:mtext></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>&#x000D7;</mml:mo><mml:mtext>Sp</mml:mtext><mml:msub><mml:mrow><mml:mtext>O</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mtext>%</mml:mtext></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>&#x000F7;</mml:mo><mml:mn>100</mml:mn><mml:mtext>&#x02003;</mml:mtext><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mtext>a</mml:mtext></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
<p>An adaptive response to chronic hypoxemia was to enhance erythropoiesis, and the increase in erythrocytes is inversely related to resting oxygen saturation in patients with sufficient iron stores and an appropriate erythropoietic response (<xref ref-type="bibr" rid="B14">14</xref>). The estimation formula of CaO<sub>2</sub> also supports this inverse relationship. Therefore, we presumed that CaO<sub>2</sub> could assess whether patients had adequate secondary erythrocytosis. If cyanotic children had sufficient compensation for preoperative Hb concentration, they could obtain a similar CaO<sub>2</sub> to healthy children:</p>
<disp-formula id="E2"><mml:math id="M2"><mml:mtable columnalign='left'><mml:mtr><mml:mtd><mml:mn>1</mml:mn><mml:mo>.</mml:mo><mml:mn>39</mml:mn><mml:mo>&#x000D7;</mml:mo><mml:mtext>Preoperative&#x000A0;Hb&#x02009;</mml:mtext><mml:mo>&#x000D7;</mml:mo><mml:mtext>&#x02009;preoperative&#x000A0;Sp</mml:mtext><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo><mml:mn>39</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;</mml:mtext><mml:mtable columnalign='right'><mml:mtr columnalign='right'><mml:mtd columnalign='right'><mml:mrow><mml:mtable columnalign='left'><mml:mtr columnalign='left'><mml:mtd columnalign='left'><mml:mrow><mml:mo>&#x000D7;</mml:mo><mml:mtext>Normal&#x000A0;Hb</mml:mtext><mml:mo>&#x000D7;</mml:mo><mml:mtext>normal&#x000A0;Sp</mml:mtext><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mtext>&#x02003;</mml:mtext><mml:mo stretchy='false'>(</mml:mo><mml:mi>b</mml:mi><mml:mo stretchy='false'>)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
<disp-formula id="E3"><mml:math id="M3"><mml:mtable columnalign='left'><mml:mtr><mml:mtd><mml:mtext>Preoperative&#x000A0;Hb</mml:mtext><mml:mo>&#x000D7;</mml:mo><mml:msub><mml:mtext>preoperativeSpO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mtext>Normal&#x000A0;Hb</mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;</mml:mtext><mml:mo>&#x000D7;</mml:mo><mml:mtext>normal&#x000A0;Sp</mml:mtext><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mtext>&#x02003;</mml:mtext><mml:mo stretchy='false'>(</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy='false'>)</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
<p>The age-adjusted lower limits of normal hemoglobin (aaHb) in healthy children are 14.5 g/dl for neonates, 9 g/dl at 2 months, 10.5 g/dl at 6 months, 11.5 g/dl at 2 years, and 12 g/dl and 13 g/dl in adolescent girls and boys, respectively (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Therefore, the formula can be converted as follows:</p>
<disp-formula id="E4"><mml:math id="M4"><mml:mrow><mml:mtable columnalign='left'><mml:mtr columnalign='left'><mml:mtd columnalign='left'><mml:mrow><mml:mtext>Preoperative&#x000A0;Hb</mml:mtext><mml:mo>&#x000D7;</mml:mo><mml:msub><mml:mrow><mml:mtext>preoperativeSpO</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>&#x02265;</mml:mo><mml:mtext>aaHb</mml:mtext><mml:mo>&#x000D7;</mml:mo><mml:mtext>normal&#x000A0;Sp</mml:mtext><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy='false'>(</mml:mo><mml:mi>d</mml:mi><mml:mo stretchy='false'>)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
<p>In contrast, the presence of preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb &#x000D7; normal SpO<sub>2</sub> indicated that CaO<sub>2</sub> in cyanotic children was lower than that in healthy children, with insufficient compensation for preoperative Hb concentration. The values of normal SpO<sub>2</sub> range from 95 to 100%.</p>
</sec>
<sec>
<title>Statistical Analysis</title>
<p>Continuous variables are reported as the mean &#x000B1; standard deviation or median (range). Categorical variables are presented as frequency counts and percentages and were analyzed using the Chi-squared test. If appropriate, Fisher&#x00027;s exact tests were performed. The optimal cutoff value of the continuous variables used to predict the composite outcome was calculated using Youden&#x00027;s index after performing receiver operating characteristic curve analysis. In the propensity-score matching analysis, the presence or absence of preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb &#x000D7; normal SpO<sub>2</sub> was entered in the model as a dependent variable, and covariates that should be statistically (<italic>P</italic> &#x0003C; 0.100 in the Chi-squared test) associated with the composite outcome were included in the model as independent variables. They were preoperative SpO<sub>2</sub>, age, RACHS-1, type of heart defect, clubbed fingers or toes, preoperative comorbidity, patent ductus arteriosus, pulmonary arterial hypertension and aortopulmonary collateral arteries. The matching ratio was 1:1, and the matching tolerance was 0.001. Before multivariate analysis, collinearity was diagnosed. If the variance proportion &#x0003E;0.5 existed in two or more covariates in the same dimension or a variance inflation factor (VIF) was up to 3, the presence of collinearity was considered. Multivariate analysis was performed using the backward stepwise method of logistic regression. All statistical tests were performed using SPSS v.24 (IBM Corp., Armonk, NY), and a two-sided <italic>P</italic> &#x0003C; 0.05 indicated a statistically significant difference.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Characteristics of Children</title>
<p>In total, 805 children met the inclusion criteria, and 28 cases were excluded: 22 children had preoperative invasive or noninvasive mechanical ventilation, preoperative Hb or resting SpO<sub>2</sub> was unavailable in 4 cases, and 2 children received preoperative blood transfusions. Among the remaining 777 eligible children, the median age was 24.7 (range 0&#x02013;214) months, with 359 girls and 418 boys. The top 5 heart defects were tetralogy of Fallot (39.3%), double-outlet right ventricle (16.4%), single ventricle (8.3%), pulmonary atresia (8.1%), and transposition of great arteries (7.4%). The remaining defect types included hypoplastic right heart syndrome, total anomalous pulmonary vein drainage, hypoplastic left heart syndrome, complete atrioventricular septal defect, interrupted aortic arch, truncus arteriosus and other rare defects. In-hospital mortality was 6.3%, and the incidence of the composite outcome was 40.4%.</p>
</sec>
<sec>
<title>The Distribution and Linear Relation of Preoperative Hb and Resting SpO<sub>2</sub> in Cyanotic Children</title>
<p>Preoperative resting SpO<sub>2</sub> without oxygen therapy and preoperative Hb concentration were in accordance with normal distributions (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>). The mean values were 77.5% &#x000B1;7.7% and 16.7 &#x000B1; 3.4 g/dl, respectively. The linear relation analysis showed a poor correlation between preoperative Hb and SpO<sub>2</sub> (<italic>R</italic><sup>2</sup> = 0.072, <xref ref-type="fig" rid="F1">Figure 1C</xref>). The mean value of preoperative Hb &#x000D7; SpO<sub>2</sub> was 12.9 &#x000B1; 2.6 g/dl and a normal distribution was also shown (<xref ref-type="fig" rid="F1">Figure 1D</xref>). To predict the composite outcome, Youden&#x00027;s index showed that 100% was the optimal cutoff value in the range of normal SpO<sub>2</sub> (95% to 100%) to evaluate whether cyanotic children had sufficient compensation for preoperative Hb concentration.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>The distribution and linear relationship of resting pulse oxygen saturation (SpO<sub>2</sub>) and preoperative hemoglobin (Hb) concentration in cyanotic children. <bold>(A)</bold> Distribution of resting SpO<sub>2</sub>; <bold>(B)</bold> distribution of preoperative Hb concentration; <bold>(C)</bold> linear relationship between preoperative Hb concentration and resting SpO<sub>2</sub>; <bold>(D)</bold> distribution of the preoperative Hb &#x000D7; SpO<sub>2</sub> value.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fped-09-762241-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Association of Preoperative Hb Level and Postoperative Mortality and Morbidity</title>
<p>The rates of preoperative Hb &#x0003C; aaHb and preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb were 4.5% and 21.6%, respectively. Both of them were significantly associated with the composite outcome (<xref ref-type="table" rid="T1">Table 1</xref>), but preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb was associated with more types of severe postoperative events, especially associated with higher in-hospital mortality (12.5% vs. 4.6%, <italic>P</italic> &#x0003C; 0.001, <xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p> Association of preoperative hemoglobin levels with postoperative outcomes in cyanotic children.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Variable</bold></th>
<th valign="top" align="center"><bold>Hb &#x0003C; aaHb</bold><break/> <bold>(<italic><bold>n &#x0003D;</bold></italic> 742)</bold></th>
<th valign="top" align="center"><bold>Hb &#x02265; aaHb</bold><break/> <bold>(<italic><bold>n &#x0003D;</bold></italic> 35)</bold></th>
<th valign="top" align="center"><italic><bold>P</bold></italic><bold>-value</bold></th>
<th valign="top" align="center"><bold>Hb &#x000D7; SpO<sub><bold>2</bold></sub> &#x0003C; aaHb</bold><break/> <bold>(<italic><bold>n &#x0003D;</bold></italic> 609)</bold></th>
<th valign="top" align="center"><bold>Hb &#x000D7; SpO<sub><bold>2</bold></sub> &#x02265; aaHb</bold><break/> <bold>(<italic><bold>n &#x0003D;</bold></italic> 168)</bold></th>
<th valign="top" align="center"><italic><bold>P</bold></italic><bold>-value</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Reoperation</td>
<td valign="top" align="center">31 (4.2%)</td>
<td valign="top" align="center">1 (2.9%)</td>
<td valign="top" align="center">&#x0003E;0.999<xref ref-type="table-fn" rid="TN1a"><sup>a</sup></xref></td>
<td valign="top" align="center">22 (3.6%)</td>
<td valign="top" align="center">10 (6.0%)</td>
<td valign="top" align="center">0.177</td>
</tr>
<tr>
<td valign="top" align="left">Severe hemorrhage</td>
<td valign="top" align="center">43 (5.8%)</td>
<td valign="top" align="center">2 (5.7%)</td>
<td valign="top" align="center">&#x0003E;0.999<xref ref-type="table-fn" rid="TN1a"><sup>a</sup></xref></td>
<td valign="top" align="center">29 (4.8%)</td>
<td valign="top" align="center">16 (9.5%)</td>
<td valign="top" align="center">0.019</td>
</tr>
<tr>
<td valign="top" align="left">In-hospital death</td>
<td valign="top" align="center">45 (6.1%)</td>
<td valign="top" align="center">4 (11.4%)</td>
<td valign="top" align="center">0.270<xref ref-type="table-fn" rid="TN1a"><sup>a</sup></xref></td>
<td valign="top" align="center">28 (4.6%)</td>
<td valign="top" align="center">21 (12.5%)</td>
<td valign="top" align="center">&#x0003C; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Cardiac arrest</td>
<td valign="top" align="center">65 (8.8%)</td>
<td valign="top" align="center">7 (20.0%)</td>
<td valign="top" align="center">0.035<xref ref-type="table-fn" rid="TN1a"><sup>a</sup></xref></td>
<td valign="top" align="center">40 (6.6%)</td>
<td valign="top" align="center">32 (19.0%)</td>
<td valign="top" align="center">&#x0003C; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Invasive ventilation &#x02265;168 h<xref ref-type="table-fn" rid="TN1b"><sup>b</sup></xref></td>
<td valign="top" align="center">166 (22.4%)</td>
<td valign="top" align="center">18 (51.4%)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td valign="top" align="center">121 (19.9%)</td>
<td valign="top" align="center">63 (37.5%)</td>
<td valign="top" align="center">&#x0003C; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Sepsis</td>
<td valign="top" align="center">207 (27.9%)</td>
<td valign="top" align="center">21 (60.0%)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td valign="top" align="center">141 (23.2%)</td>
<td valign="top" align="center">87 (51.8%)</td>
<td valign="top" align="center">&#x0003C; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Composite outcome</td>
<td valign="top" align="center">286 (38.5%)</td>
<td valign="top" align="center">28 (80.0%)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td valign="top" align="center">197 (32.3%)</td>
<td valign="top" align="center">117 (69.6%)</td>
<td valign="top" align="center">&#x0003C; 0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1a"><label>a</label><p><italic>Fisher&#x00027;s exact test</italic>.</p></fn>
<fn id="TN1b"><label>b</label><p><italic>The 75th percentile of invasive ventilation duration was 167 h. aaHb, age-adjusted lower limit of normal hemoglobin in healthy children; Hb, hemoglobin; SpO<sub>2</sub>, pulse oxygen saturation</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Risk Factors for Postoperative Composite Outcome and In-hospital Death</title>
<p>In addition to the preoperative Hb level, Chi-squared tests showed that age at the cutoff value of 2 years, RACHS-1 at the cutoff value of 3 scores, type of heart defect, clubbed fingers or toes, preoperative comorbidity and patent ductus arteriosus were significantly (<italic>P</italic> &#x0003C; 0.05) associated with the postoperative composite outcome, and SpO<sub>2</sub> at the cutoff value of 74.1% (<italic>P</italic> = 0.084), pulmonary arterial hypertension (<italic>P</italic> = 0.092) and aortopulmonary collateral arteries (<italic>P</italic> = 0.095) were slightly associated with the composite outcome. Meanwhile, preoperative comorbidity, patent ductus arteriosus, type of heart defect and RACHS-1 showed statistical associations with in-hospital death at the level of <italic>P</italic> &#x0003C; 0.05, and age and pulmonary arterial hypertension were slightly related to in-hospital death with a <italic>P-</italic>value of 0.050-0.100. Other factors were not associated with the composite outcome or in-hospital death in the univariate analyses.</p>
<p>We found that clinical factors were significantly associated with preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb (<xref ref-type="table" rid="T2">Table 2</xref>). Therefore, collinearity diagnostics was performed. The results showed that the VIF values ranged from 1.061 to 1.300, and a variance proportion &#x0003E;0.5 was not observed in two or more covariates in the same dimension. Therefore, the collinearity was poor, and these covariates were suitable for multivariate analysis. Subsequently, multivariable logistic regression analysis was carried out using the backward stepwise method and showed that the presence of preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb was associated with increased risks of in-hospital death [odds ratio (<italic>OR</italic>) = 2.149; 95% confidence interval (<italic>CI</italic>) = 1.147&#x02013;4.027, <italic>P</italic> = 0.017] and the composite outcome (<italic>OR</italic> = 4.092, 95% <italic>CI</italic> = 2.748&#x02013;6.095, <italic>P</italic> &#x0003C; 0.001) in the entire population (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Confounding factors associated with the preoperative hemoglobin level in cyanotic children.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Variable</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>All children (<italic><bold>N &#x0003D;</bold></italic> 777)</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Matched children (<italic><bold>N &#x0003D;</bold></italic> 282)</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>Hb &#x000D7; SpO<sub><bold>2</bold></sub> &#x0003C; aaHb</bold><break/> <bold>(<italic><bold>n &#x0003D;</bold></italic> 609)</bold></th>
<th valign="top" align="center"><bold>Hb &#x000D7; SpO<sub><bold>2</bold></sub> &#x02265; aaHb</bold><break/> <bold>(<italic><bold>n &#x0003D;</bold></italic> 168)</bold></th>
<th valign="top" align="center"><italic><bold>P</bold></italic><bold>-value</bold></th>
<th valign="top" align="center"><bold>Hb &#x000D7; SpO<sub><bold>2</bold></sub> &#x0003C; aaHb</bold><break/> <bold>(<italic><bold>n &#x0003D;</bold></italic> 141)</bold></th>
<th valign="top" align="center"><bold>Hb &#x000D7; SpO<sub><bold>2</bold></sub> &#x02265; aaHb</bold><break/> <bold>(<italic><bold>n &#x0003D;</bold></italic> 141)</bold></th>
<th valign="top" align="center"><italic><bold>P</bold></italic><bold>-value</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><bold>SpO</bold><sub><bold>2</bold></sub></td>
<td/>
<td/>
<td valign="top" align="center">&#x0003C; 0.001</td>
<td/>
<td/>
<td valign="top" align="center">0.632</td>
</tr>
<tr>
<td valign="top" align="left">74.1&#x02013;90%</td>
<td valign="top" align="center">439 (72.1%)</td>
<td valign="top" align="center">93 (55.4%)</td>
<td/>
<td valign="top" align="center">76 (53.9%)</td>
<td valign="top" align="center">80 (56.7%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x0003C;74.1%<xref ref-type="table-fn" rid="TN2a"><sup>a</sup></xref></td>
<td valign="top" align="center">170 (27.9%)</td>
<td valign="top" align="center">75 (44.6%)</td>
<td/>
<td valign="top" align="center">65 (46.1%)</td>
<td valign="top" align="center">61 (43.3%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Age</bold></td>
<td/>
<td/>
<td valign="top" align="center">&#x0003C; 0.001</td>
<td/>
<td/>
<td valign="top" align="center">0.323</td>
</tr>
<tr>
<td valign="top" align="left">&#x0003C;2 y<xref ref-type="table-fn" rid="TN2a"><sup>a</sup></xref></td>
<td valign="top" align="center">271 (44.5%)</td>
<td valign="top" align="center">110 (65.5%)</td>
<td/>
<td valign="top" align="center">93 (66.0%)</td>
<td valign="top" align="center">85 (60.3%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">2y &#x02013; &#x0003C;18 y</td>
<td valign="top" align="center">338 (55.5%)</td>
<td valign="top" align="center">58 (34.5%)</td>
<td/>
<td valign="top" align="center">48 (34.0%)</td>
<td valign="top" align="center">56 (39.7%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>RACHS-1</bold></td>
<td/>
<td/>
<td valign="top" align="center">&#x0003C; 0.001</td>
<td/>
<td/>
<td valign="top" align="center">0.404</td>
</tr>
<tr>
<td valign="top" align="left">1&#x02013;2</td>
<td valign="top" align="center">339 (55.7%)</td>
<td valign="top" align="center">67 (39.9%)</td>
<td/>
<td valign="top" align="center">71 (50.4%)</td>
<td valign="top" align="center">64 (45.4%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">3&#x02013;6</td>
<td valign="top" align="center">270 (44.3%)</td>
<td valign="top" align="center">101 (60.1%)</td>
<td/>
<td valign="top" align="center">70 (49.6%)</td>
<td valign="top" align="center">77 (54.6%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Type of heart defect</bold></td>
<td/>
<td/>
<td valign="top" align="center">&#x0003C; 0.001</td>
<td/>
<td/>
<td valign="top" align="center">0.981</td>
</tr>
<tr>
<td valign="top" align="left">Tetralogy of Fallot</td>
<td valign="top" align="center">249 (40.9%)</td>
<td valign="top" align="center">56 (33.3%)</td>
<td/>
<td valign="top" align="center">57 (40.4%)</td>
<td valign="top" align="center">52 (36.9%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Double-outlet right ventricle</td>
<td valign="top" align="center">99 (16.3%)</td>
<td valign="top" align="center">29 (17.3%)</td>
<td/>
<td valign="top" align="center">29 (20.6%)</td>
<td valign="top" align="center">28 (19.9%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Single ventricle</td>
<td valign="top" align="center">51 (8.4%)</td>
<td valign="top" align="center">14 (8.3%)</td>
<td/>
<td valign="top" align="center">13 (9.2%)</td>
<td valign="top" align="center">14 (9.9%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Pulmonary atresia</td>
<td valign="top" align="center">56 (9.2%)</td>
<td valign="top" align="center">7 (4.2%)</td>
<td/>
<td valign="top" align="center">5 (3.5%)</td>
<td valign="top" align="center">7 (5.0%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Transposition of great arteries</td>
<td valign="top" align="center">31 (5.1%)</td>
<td valign="top" align="center">27 (16.1%)</td>
<td/>
<td valign="top" align="center">9 (6.4%)</td>
<td valign="top" align="center">10 (7.1%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="center">123 (20.2%)</td>
<td valign="top" align="center">35 (20.8%)</td>
<td/>
<td valign="top" align="center">28 (19.9%)</td>
<td valign="top" align="center">30 (21.3%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Clubbed fingers or toes</bold></td>
<td/>
<td/>
<td valign="top" align="center">&#x0003C; 0.001</td>
<td/>
<td/>
<td valign="top" align="center">0.461</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">281 (46.1%)</td>
<td valign="top" align="center">115 (68.5%)</td>
<td/>
<td valign="top" align="center">85 (60.3%)</td>
<td valign="top" align="center">91 (64.5%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">328 (53.9%)</td>
<td valign="top" align="center">53 (31.5%)</td>
<td/>
<td valign="top" align="center">56 (39.7%)</td>
<td valign="top" align="center">50 (35.5%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Preoperative comorbidity</bold></td>
<td/>
<td/>
<td valign="top" align="center">0.001</td>
<td/>
<td/>
<td valign="top" align="center">0.776</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">590 (96.9%)</td>
<td valign="top" align="center">153 (91.1%)</td>
<td/>
<td valign="top" align="center">134 (95.0%)</td>
<td valign="top" align="center">135 (95.7%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">19 (3.1%)</td>
<td valign="top" align="center">15 (8.9%)</td>
<td/>
<td valign="top" align="center">7 (5.0%)</td>
<td valign="top" align="center">6 (4.3%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Aortopulmonary collateral arteries</bold></td>
<td/>
<td/>
<td valign="top" align="center">0.028</td>
<td/>
<td/>
<td valign="top" align="center">0.382</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">364 (59.8%)</td>
<td valign="top" align="center">116 (69.0%)</td>
<td/>
<td valign="top" align="center">88 (62.4%)</td>
<td valign="top" align="center">95 (67.4%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">245 (40.2%)</td>
<td valign="top" align="center">52 (31.0%)</td>
<td/>
<td valign="top" align="center">53 (37.6%)</td>
<td valign="top" align="center">46 (32.6%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Patent ductus arteriosus</bold></td>
<td/>
<td/>
<td valign="top" align="center">0.045</td>
<td/>
<td/>
<td valign="top" align="center">&#x0003E; 0.999</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">440 (72.2%)</td>
<td valign="top" align="center">108 (64.3%)</td>
<td/>
<td valign="top" align="center">98 (69.5%)</td>
<td valign="top" align="center">98 (69.5%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">169 (27.8%)</td>
<td valign="top" align="center">60 (35.7%)</td>
<td/>
<td valign="top" align="center">43 (30.5%)</td>
<td valign="top" align="center">43 (30.5%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Pulmonary arterial hypertension</bold></td>
<td/>
<td/>
<td valign="top" align="center">0.053</td>
<td/>
<td/>
<td valign="top" align="center">0.721</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">559 (91.8%)</td>
<td valign="top" align="center">146 (86.9%)</td>
<td/>
<td valign="top" align="center">122 (86.5%)</td>
<td valign="top" align="center">124 (87.9%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">50 (8.2%)</td>
<td valign="top" align="center">22 (13.1%)</td>
<td/>
<td valign="top" align="center">19 (13.5%)</td>
<td valign="top" align="center">17 (12.1%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Residence altitude</bold></td>
<td/>
<td/>
<td valign="top" align="center">0.055</td>
<td/>
<td/>
<td valign="top" align="center">0.378</td>
</tr>
<tr>
<td valign="top" align="left">&#x0003C;1,500 m</td>
<td valign="top" align="center">553 (90.8%)</td>
<td valign="top" align="center">144 (85.7%)</td>
<td/>
<td valign="top" align="center">125 (88.7%)</td>
<td valign="top" align="center">120 (85.1%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x02265;1,500 m</td>
<td valign="top" align="center">56 (9.2%)</td>
<td valign="top" align="center">24 (14.3%)</td>
<td/>
<td valign="top" align="center">16 (11.3%)</td>
<td valign="top" align="center">21 (14.9%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Gender</bold></td>
<td/>
<td/>
<td valign="top" align="center">0.247</td>
<td/>
<td/>
<td valign="top" align="center">0.471</td>
</tr>
<tr>
<td valign="top" align="left">Boy</td>
<td valign="top" align="center">321 (52.7%)</td>
<td valign="top" align="center">97 (57.7%)</td>
<td/>
<td valign="top" align="center">83 (58.9%)</td>
<td valign="top" align="center">77 (54.6%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Girl</td>
<td valign="top" align="center">288 (47.3%)</td>
<td valign="top" align="center">71 (42.3%)</td>
<td/>
<td valign="top" align="center">58 (41.1%)</td>
<td valign="top" align="center">64 (45.4%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Cardiac surgery history</bold></td>
<td/>
<td/>
<td valign="top" align="center">0.516</td>
<td/>
<td/>
<td valign="top" align="center">0.164</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">552 (90.6%)</td>
<td valign="top" align="center">155 (92.3%)</td>
<td/>
<td valign="top" align="center">134 (95.0%)</td>
<td valign="top" align="center">128 (90.8%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">57 (9.4%)</td>
<td valign="top" align="center">13 (7.7%)</td>
<td/>
<td valign="top" align="center">7 (5.0%)</td>
<td valign="top" align="center">13 (9.2%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><bold>Left ventricular ejection fraction</bold><sup><bold>b</bold></sup></td>
<td/>
<td/>
<td valign="top" align="center">&#x0003E;0.999<xref ref-type="table-fn" rid="TN2c"><sup>c</sup></xref></td>
<td/>
<td/>
<td valign="top" align="center">&#x0003E;0.999<xref ref-type="table-fn" rid="TN2c"><sup>c</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">&#x0003C;55%</td>
<td valign="top" align="center">595 (97.7%)</td>
<td valign="top" align="center">165 (98.2%)</td>
<td/>
<td valign="top" align="center">138 (97.9%)</td>
<td valign="top" align="center">138 (97.9%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x02265;55%</td>
<td valign="top" align="center">14 (2.3%)</td>
<td valign="top" align="center">3 (1.8%)</td>
<td/>
<td valign="top" align="center">3 (2.1%)</td>
<td valign="top" align="center">3 (2.1%)</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN2a"><label>a</label><p><italic>The optimal cutoff value to predict the composite outcome</italic>.</p></fn>
<fn id="TN2b"><label>b</label><p><italic>For children with a single ventricle, the ejection fraction of the single ventricle was recorded</italic>.</p></fn>
<fn id="TN2c"><label>c</label><p><italic>Fisher&#x00027;s exact test. aaHb, age-adjusted lower limit of normal hemoglobin in healthy children; Hb, hemoglobin; RACHS-1, the Risk Adjustment for Congenital Heart Surgery 1; SpO<sub>2</sub>, pulse oxygen saturation</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Multivariable analysis for the postoperative outcomes.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Outcome</bold></th>
<th valign="top" align="center"><bold>Variable</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>All patients (</bold><italic><bold>N</bold></italic> <bold>&#x0003D; 779)</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Matched patients (</bold><italic><bold>N</bold></italic> <bold>&#x0003D; 282)</bold></th>
</tr>
<tr>
<th/>
<th/>
<th valign="top" align="center"><italic><bold>OR</bold></italic> <bold>(95% <italic><bold>CI</bold></italic>)</bold></th>
<th valign="top" align="center"><italic><bold>P</bold></italic><bold>-value</bold></th>
<th valign="top" align="center"><italic><bold>OR</bold></italic> <bold>(95% <italic><bold>CI</bold></italic>)</bold></th>
<th valign="top" align="center"><italic><bold>P</bold></italic><bold>-value</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="6"><bold>In-hospital death</bold></td>
</tr>
<tr>
<td valign="top" align="left">RACHS-1 &#x02265; 3</td>
<td valign="top" align="center">3.258 (1.557&#x02013;6.816)</td>
<td valign="top" align="center">0.002</td>
<td valign="top" align="center">3.917 (1.418&#x02013;10.816)</td>
<td valign="top" align="center">0.008</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Patent ductus arteriosus</td>
<td valign="top" align="center">2.256 (1.216&#x02013;4.184)</td>
<td valign="top" align="center">0.010</td>
<td valign="top" align="center">3.270 (1.424&#x02013;7.512)</td>
<td valign="top" align="center">0.005</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Preoperative comorbidity</td>
<td valign="top" align="center">3.023 (1.234&#x02013;7.406)</td>
<td valign="top" align="center">0.016</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb</td>
<td valign="top" align="center">2.149 (1.147&#x02013;4.027)</td>
<td valign="top" align="center">0.017</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td/>
</tr>
<tr>
<td valign="top" align="left" colspan="6"><bold>Composite outcome</bold></td>
</tr>
<tr>
<td valign="top" align="left">Preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb</td>
<td valign="top" align="center">4.092 (2.748&#x02013;6.095)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td valign="top" align="center">2.277 (1.366&#x02013;3.795)</td>
<td valign="top" align="center">0.002</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Age &#x02265; 2 y</td>
<td valign="top" align="center">0.403 (0.289&#x02013;0.562)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td valign="top" align="center">0.385 (0.227&#x02013;0.651)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">RACHS-1 &#x02265; 3</td>
<td valign="top" align="center">2.248 (1.616&#x02013;3.127)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td valign="top" align="center">2.455 (1.476&#x02013;4.085)</td>
<td valign="top" align="center">0.001</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Aortopulmonary collateral arteries</td>
<td valign="top" align="center">1.686 (1.210&#x02013;2.348)</td>
<td valign="top" align="center">0.002</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Patent ductus arteriosus</td>
<td valign="top" align="center">1.687 (1.184&#x02013;2.404)</td>
<td valign="top" align="center">0.004</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Preoperative comorbidity</td>
<td valign="top" align="center">2.673 (1.088&#x02013;6.566)</td>
<td valign="top" align="center">0.032</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>aaHb, age-adjusted lower limit of normal hemoglobin; CI, confidence interval; Hb, hemoglobin; OR, odds ratio; RACHS-1, the Risk Adjustment for Congenital Heart Surgery 1; SpO<sub>2</sub>, pulse oxygen saturation</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>As confounding factors may still influence the statistical results despite multivariate analysis, we further conducted a propensity-score matching analysis. We successfully matched 141 children with preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb to 141 children with preoperative Hb &#x000D7; SpO<sub>2</sub> &#x02265; aaHb. All confounders were balanced in the matched cohorts (<xref ref-type="table" rid="T2">Table 2</xref>). Although preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb was not associated with in-hospital death, multivariable logistic regression analysis confirmed that preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb was still an independent prognostic factor for the composite outcome (<italic>OR</italic> = 2.277, 95% <italic>CI</italic> = 1.366&#x02013;3.795, <italic>P</italic> = 0.002) in the matched cohorts (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Optimal preoperative Hb level and anemia criteria are difficult to define in cyanotic children (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). The 15 g/dl cutoff value was adopted in the study published by Okoromah et al. (<xref ref-type="bibr" rid="B5">5</xref>). This value was significantly higher than the lower limits of normal Hb ranges of all age groups of healthy children (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B19">19</xref>). However, a fixed Hb cutoff value may not be appropriate for cyanotic children because the severity of compensatory erythrocytosis is not fixed but inversely correlated with resting SpO<sub>2</sub> (<xref ref-type="bibr" rid="B14">14</xref>). In cyanotic adults with compensatory erythrocytosis, a strong linear correlation was found between Hb and SpO<sub>2</sub> (Hb = 61 &#x02013; SpO<sub>2</sub>/2) (<xref ref-type="bibr" rid="B20">20</xref>). In addition to oxygen saturation, age may also influence the Hb level of children (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B19">19</xref>). In children with cyanotic heart disease, the regression equation was found as follows: Hb concentratio<italic>n</italic> = 34.4 &#x02013; 0.22 &#x000D7; (aortic oxygen saturation) &#x0002B; 0.14 &#x000D7; age (<xref ref-type="bibr" rid="B21">21</xref>). However, this regression equation was restricted to children with sufficient iron stores and oxygen saturation &#x0003E;75% (<xref ref-type="bibr" rid="B21">21</xref>). Based on the theory of an inverse relationship between the severity of compensatory erythrocytosis and resting oxygen saturation (<xref ref-type="bibr" rid="B14">14</xref>) and the estimation formula of CaO<sub>2</sub> (<xref ref-type="bibr" rid="B18">18</xref>), we presumed that the value of preoperative Hb &#x000D7; SpO<sub>2</sub> can evaluate whether cyanotic children achieved adequate Hb compensation. If the value of preoperative Hb &#x000D7; SpO<sub>2</sub> of cyanotic children was below the lower limit of normal Hb of each age group, this indicated that the preoperative Hb concentration was not sufficient to obtain similar CaO<sub>2</sub> to healthy children, and preoperative anemia would be considered.</p>
<p>Preoperative anemia is common in neonates and children undergoing noncardiac operations, with an estimated incidence of 24&#x02013;32% (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Similarly, the incidence was 23% in acyanotic children with a ventricular septal defect or an atrioventricular canal (<xref ref-type="bibr" rid="B4">4</xref>). However, the rate of preoperative anemia was only 4.5% in our cyanotic children if the diagnosis of anemia was made based on the presence of actual Hb concentration &#x0003C; aaHb. Hypoxemia may induce secondary erythrocytosis and then increase the hemoglobin concentration of cyanotic patients (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Obviously, the incidence of preoperative anemia in cyanotic children would be seriously underestimated by the actual Hb concentration, but the anemia rate could increase to 21.6% according to the Hb &#x000D7; SpO<sub>2</sub> value, which may improve the detection rate of preoperative anemia in cyanotic children. Moreover, univariate analyses indicated that the presence of preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb was associated with more types of severe postoperative events, including in-hospital mortality (<xref ref-type="table" rid="T1">Table 1</xref>). Both multivariable logistic regression analysis and propensity-score matching analysis showed that preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb was significantly associated with the composite postoperative outcome (<xref ref-type="table" rid="T3">Table 3</xref>). This was consistent with the findings that preoperative anemia was associated with poor postoperative outcomes in adults undergoing cardiac surgery (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>) and in neonates and children undergoing noncardiac surgery (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Therefore, compared with the actual Hb concentration, the value of Hb &#x000D7; SpO<sub>2</sub> below the lower limit of normal Hb of each age group has stronger prognostic power and may be more suitable to evaluate preoperative anemia in children with cyanotic CHD.</p>
<p>The reasons for poor prognosis among anemic patients undergoing surgery are not well known. One explanation is that anemia may be the representation of other confounding factors related to poor prognosis (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Erythrocytosis does not tend to stabilize until hypoxemia has been present for quite some time, so preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb was more likely to occur in children without adequate time for the response to hypoxemia, demonstrated by our results that the rates of preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb in children younger than 6 months (33.7%) and aged 6 months to 2 years (27.1%) were higher than those in other age groups (14.2&#x02013;17.2%). Meanwhile, younger age was an independent risk factor for the postoperative composite outcome (<xref ref-type="table" rid="T3">Table 3</xref>), which was consistent with the finding in acute kidney injury after congenital cardiac surgery (<xref ref-type="bibr" rid="B8">8</xref>). We also found that the incidences of Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb were higher in children with patent ductus arteriosus (26.2%) or transposition of great arteries (46.6%) and were lower in children with aortopulmonary collateral arteries (17.5%) or clubbed fingers or toes (13.9%). Compared to the entire population with a median age of 24.7 months, the median age was younger in children with PDA (13.5 months) or transposition of great arteries (10.3 months) and was older in children with aortopulmonary collateral arteries (31.8 months) or clubbed fingers or toes (48.9 months). Children with transposition of great arteries or duct-dependent CHD usually require early diagnosis and intervention (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>) and may not have enough time to compensate for hemoglobin. In contrast, the presence of aortopulmonary collateral arteries and clubbed fingers and toes generally indicates that hypoxemia has existed for a long time. Therefore, anatomic and pathophysiologic factors may partially explain the prognostic power of Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb. A previous study revealed that aortic oxygen saturation below 75&#x02013;80% was associated with an increase in erythropoietin titer, suggesting that adequate and stable erythrocytic response is not easy for patients with deep hypoxemia (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B26">26</xref>). Similarly, our findings showed that low SpO<sub>2</sub> (&#x0003C;74.1%) was associated with insufficient compensation for preoperative Hb concentration (Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb) (<xref ref-type="table" rid="T2">Table 2</xref>). In addition to cyanotic CHD, living at high altitudes (low oxygen environment) can also lead to elevated hemoglobin levels in patients. In this study, eighty (10.3%) patients lived at an altitude of &#x0003E;1,500 m. However, the altitude of long-term residence was only slightly related to the presence of Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb (<italic>P</italic> = 0.055), probably because children moving from high altitude to the urban area of Chengdu with a 500-m altitude had adapted to the normal oxygen environment before surgery. Therefore, we conducted a propensity score matching analysis to balance these confounding factors (<xref ref-type="table" rid="T2">Table 2</xref>). Multivariable logistic regression analysis showed that preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb was still significantly associated with the composite outcome in the matched cohorts (<xref ref-type="table" rid="T3">Table 3</xref>). It requires going back to the physiological function of hemoglobin. Preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb indicates a decrease in blood oxygen content in cyanotic children. This may lead to inadequate tissue oxygen delivery for metabolic needs, consequently increasing the risk of postoperative organ dysfunction (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>From the perspective of tissue oxygen delivery, preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb may be a modifiable risk factor for cardiac surgery. It is estimated that the incidence of iron deficiency is up to 47.1% in children with cyanotic CHD (<xref ref-type="bibr" rid="B27">27</xref>). Despite the lack of high-level evidence, the consensus for patient blood management recommends early management anemia before cardiac surgery, including preoperative iron supplementation for iron-deficiency anemia and consideration of erythropoietin in patients with specific conditions (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B28">28</xref>). According to the formula for calculating oxygen content (<xref ref-type="bibr" rid="B18">18</xref>), improvement of oxygen saturation may also be a strategy for selected children with cyanotic CHD, such as oxygen administration in concomitant parenchymal lung disease or deep cyanosis (<xref ref-type="bibr" rid="B29">29</xref>) and prostanoid pulmonary vasodilator use in severe pulmonary arterial hypertension (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>) and duct-dependent CHD (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B31">31</xref>). However, further studies are required to determine whether these strategies can improve postoperative outcomes in cyanotic children with preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb.</p>
<p>The authors acknowledge several limitations. First, there may have been selection bias in this single-institution retrospective study. Second, pulse oximetry performs poorly when SaO<sub>2</sub> is &#x0003C;80% (<xref ref-type="bibr" rid="B32">32</xref>). The mean SpO<sub>2</sub> was 4.6% higher than that of SaO<sub>2</sub> in cyanotic children (<xref ref-type="bibr" rid="B32">32</xref>). In this study, we found that 100% was the optimal cutoff value of normal SpO<sub>2</sub> (95&#x02013;100%). Therefore, it was increased by approximately 5% on both sides of the equation (preoperative Hb &#x000D7; preoperative SpO<sub>2</sub> = normal Hb &#x000D7; normal SpO<sub>2</sub>). To some extent, this counteracted the overestimation of oxygen saturation by SpO<sub>2</sub> in cyanotic children. Meanwhile, multiple measurements of SpO<sub>2</sub> are noninvasive, convenient and cost-effective. Moreover, an association, rather than causation, was identified between preoperative Hb &#x000D7; SpO<sub>2</sub> &#x0003C; aaHb and postoperative outcomes. We could not eliminate the influence of other confounding factors such as socioeconomic status (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>) and chromosome abnormality (<xref ref-type="bibr" rid="B35">35</xref>), which were reported as prognostic factors for children with CHD but were not recorded for all children in our study.</p>
</sec>
<sec sec-type="conclusions" id="s5">
<title>Conclusion</title>
<p>Our findings suggest that a preoperative Hb &#x000D7; SpO<sub>2</sub> value below the lower limit of normal Hb is significantly associated with higher postoperative mortality and morbidity and is a potential criterion to evaluate preoperative anemia in children with cyanotic CHD. Prospective multicenter studies are required to confirm these findings.</p>
</sec>
<sec sec-type="data-availability" id="s6">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the Ethics Committee on Biomedical Research, West China Hospital of Sichuan University (Reference Number, 2019-438). Written informed consent from the participants&#x00027; legal guardian/next of kin was not required to participate in this study in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>DZ, L-JD and Y-FL: contributed to the data curation, methodology, formal analysis, original draft, and final revision. M-LT: contributed to the conceptualization, methodology, interpretation, project administration, and final revision. All authors have read and approved the final manuscript.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>This work was supported by the West China Nursing Discipline Development Special Fund Project of Sichuan University (Grant Number, HXHL19061).</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bateman</surname> <given-names>ST</given-names></name> <name><surname>Lacroix</surname> <given-names>J</given-names></name> <name><surname>Boven</surname> <given-names>K</given-names></name> <name><surname>Forbes</surname> <given-names>P</given-names></name> <name><surname>Barton</surname> <given-names>R</given-names></name> <name><surname>Thomas</surname> <given-names>NJ</given-names></name> <etal/></person-group>. <article-title>Anemia, blood loss, and blood transfusions in North American children in the intensive care unit</article-title>. <source>Am J Respir Crit Care Med.</source> (<year>2008</year>) <volume>178</volume>:<fpage>26</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200711-1637OC</pub-id><pub-id pub-id-type="pmid">18420962</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goobie</surname> <given-names>SM</given-names></name> <name><surname>Faraoni</surname> <given-names>D</given-names></name> <name><surname>Zurakowski</surname> <given-names>D</given-names></name> <name><surname>DiNardo</surname> <given-names>JA</given-names></name></person-group>. <article-title>Association of preoperative anemia with postoperative mortality in neonates</article-title>. <source>JAMA Pediatr.</source> (<year>2016</year>) <volume>170</volume>:<fpage>855</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2016.1032</pub-id><pub-id pub-id-type="pmid">27992637</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faraoni</surname> <given-names>D</given-names></name> <name><surname>DiNardo</surname> <given-names>JA</given-names></name> <name><surname>Goobie</surname> <given-names>SM</given-names></name></person-group>. <article-title>Relationship between preoperative anemia and in-hospital mortality in children undergoing noncardiac surgery</article-title>. <source>Anesth Analg.</source> (<year>2016</year>) <volume>123</volume>:<fpage>1582</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1213/ANE.0000000000001499</pub-id><pub-id pub-id-type="pmid">27870741</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>Z</given-names></name> <name><surname>Natarajan</surname> <given-names>G</given-names></name> <name><surname>Sallaam</surname> <given-names>S</given-names></name> <name><surname>Bondarenko</surname> <given-names>I</given-names></name> <name><surname>Walters</surname> <given-names>HL</given-names></name> <name><surname>Delius</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Association between anemia and packed cell transfusion and outcomes of ventricular septal defect and atrioventricular canal repair in children</article-title>. <source>Pediatr Cardiol.</source> (<year>2014</year>) <volume>35</volume>:<fpage>471</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s00246-013-0808-z</pub-id><pub-id pub-id-type="pmid">24154503</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okoromah</surname> <given-names>CA</given-names></name> <name><surname>Ekure</surname> <given-names>EN</given-names></name> <name><surname>Lesi</surname> <given-names>FE</given-names></name> <name><surname>Okunowo</surname> <given-names>WO</given-names></name> <name><surname>Tijani</surname> <given-names>BO</given-names></name> <name><surname>Okeiyi</surname> <given-names>JC</given-names></name></person-group>. <article-title>Prevalence, profile and predictors of malnutrition in children with congenital heart defects: a case-control observational study</article-title>. <source>Arch Dis Child.</source> (<year>2011</year>) <volume>96</volume>:<fpage>354</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1136/adc.2009.176644</pub-id><pub-id pub-id-type="pmid">21266339</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname> <given-names>JF</given-names></name> <name><surname>Shah</surname> <given-names>MD</given-names></name> <name><surname>Kantor</surname> <given-names>PF</given-names></name> <name><surname>Rossano</surname> <given-names>JW</given-names></name> <name><surname>Shaddy</surname> <given-names>RE</given-names></name> <name><surname>Chiou</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Prevalence and severity of anemia in children hospitalized with acute heart failure</article-title>. <source>Congenit Heart Dis.</source> (<year>2016</year>) <volume>11</volume>:<fpage>622</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/chd.12355</pub-id><pub-id pub-id-type="pmid">27060888</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dimopoulos</surname> <given-names>K</given-names></name> <name><surname>Diller</surname> <given-names>GP</given-names></name> <name><surname>Giannakoulas</surname> <given-names>G</given-names></name> <name><surname>Petraco</surname> <given-names>R</given-names></name> <name><surname>Chamaidi</surname> <given-names>A</given-names></name> <name><surname>Karaoli</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Anemia in adults with congenital heart disease relates to adverse outcome</article-title>. <source>J Am Coll Cardiol.</source> (<year>2009</year>) <volume>54</volume>:<fpage>2093</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2009.06.050</pub-id><pub-id pub-id-type="pmid">19926019</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>SK</given-names></name> <name><surname>Hur</surname> <given-names>M</given-names></name> <name><surname>Kim</surname> <given-names>E</given-names></name> <name><surname>Kim</surname> <given-names>WH</given-names></name> <name><surname>Park</surname> <given-names>JB</given-names></name> <name><surname>Kim</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Risk Factors for acute kidney injury after congenital cardiac surgery in infants and children: a retrospective observational study</article-title>. <source>PLoS ONE.</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0166328</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0166328</pub-id><pub-id pub-id-type="pmid">27832187</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raissadati</surname> <given-names>A</given-names></name> <name><surname>Nieminen</surname> <given-names>H</given-names></name> <name><surname>Haukka</surname> <given-names>J</given-names></name> <name><surname>Sairanen</surname> <given-names>H</given-names></name> <name><surname>Jokinen</surname> <given-names>E</given-names></name></person-group>. <article-title>Late Causes of death after pediatric cardiac surgery: a 60-year population-based study</article-title>. <source>J Am Coll Cardiol.</source> (<year>2016</year>) <volume>68</volume>:<fpage>487</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2016.05.038</pub-id><pub-id pub-id-type="pmid">27470457</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Warnes</surname> <given-names>CA</given-names></name> <name><surname>Williams</surname> <given-names>RG</given-names></name> <name><surname>Bashore</surname> <given-names>TM</given-names></name> <name><surname>Child</surname> <given-names>JS</given-names></name> <name><surname>Connolly</surname> <given-names>HM</given-names></name> <name><surname>Dearani</surname> <given-names>JA</given-names></name> <etal/></person-group>. <article-title>ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons</article-title>. <source>J Am Coll Cardiol</source>. (<year>2008</year>) <volume>52</volume>:<fpage>e143</fpage>&#x02013;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.190690</pub-id><pub-id pub-id-type="pmid">19038677</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname> <given-names>NL</given-names></name> <name><surname>Marino</surname> <given-names>BS</given-names></name> <name><surname>Woo</surname> <given-names>JG</given-names></name> <name><surname>Thomsen</surname> <given-names>RW</given-names></name> <name><surname>Videb&#x00153;k</surname> <given-names>J</given-names></name> <name><surname>Laursen</surname> <given-names>HB</given-names></name> <etal/></person-group>. <article-title>Congenital heart disease with and without cyanotic potential and the long-term risk of diabetes mellitus: a population-based follow-up study</article-title>. <source>J Am Heart Assoc.</source> (<year>2016</year>) <volume>5</volume>:<fpage>e003076</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.115.003076</pub-id><pub-id pub-id-type="pmid">27402234</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faraoni</surname> <given-names>D</given-names></name> <name><surname>Meier</surname> <given-names>J</given-names></name> <name><surname>New</surname> <given-names>HV</given-names></name> <name><surname>Van der Linden</surname> <given-names>PJ</given-names></name> <name><surname>Hunt</surname> <given-names>BJ</given-names></name></person-group>. <article-title>Patient blood management for neonates and children undergoing cardiac surgery: 2019 NATA Guidelines</article-title>. <source>J Cardiothorac Vasc Anesth.</source> (<year>2019</year>) <volume>33</volume>:<fpage>3249</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1053/j.jvca.2019.03.036</pub-id><pub-id pub-id-type="pmid">31076306</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cholette</surname> <given-names>JM</given-names></name> <name><surname>Faraoni</surname> <given-names>D</given-names></name> <name><surname>Goobie</surname> <given-names>SM</given-names></name> <name><surname>Ferraris</surname> <given-names>V</given-names></name> <name><surname>Hassan</surname> <given-names>N</given-names></name></person-group>. <article-title>Patient blood management in pediatric cardiac surgery: a review</article-title>. <source>Anesth Analg.</source> (<year>2018</year>) <volume>127</volume>:<fpage>1002</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1213/ANE.0000000000002504</pub-id><pub-id pub-id-type="pmid">28991109</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname> <given-names>MS</given-names></name> <name><surname>Balaratnam</surname> <given-names>MS</given-names></name> <name><surname>Gatzoulis</surname> <given-names>MA</given-names></name></person-group>. <article-title>Clinical update: cyanotic adult congenital heart disease</article-title>. <source>Lancet.</source> (<year>2007</year>) <volume>370</volume>:<fpage>1530</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(07)61647-X</pub-id><pub-id pub-id-type="pmid">17980725</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname> <given-names>KJ</given-names></name> <name><surname>Gauvreau</surname> <given-names>K</given-names></name> <name><surname>Newburger</surname> <given-names>JW</given-names></name> <name><surname>Spray</surname> <given-names>TL</given-names></name> <name><surname>Moller</surname> <given-names>JH</given-names></name> <name><surname>Iezzoni</surname> <given-names>LI</given-names></name></person-group>. <article-title>Consensus-based method for risk adjustment for surgery for congenital heart disease</article-title>. <source>J Thorac Cardiovasc Surg.</source> (<year>2002</year>) <volume>123</volume>:<fpage>110</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1067/mtc.2002.119064</pub-id><pub-id pub-id-type="pmid">11782764</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reeves</surname> <given-names>BC</given-names></name> <name><surname>Pike</surname> <given-names>K</given-names></name> <name><surname>Rogers</surname> <given-names>CA</given-names></name> <name><surname>Brierley</surname> <given-names>RC</given-names></name> <name><surname>Stokes</surname> <given-names>EA</given-names></name> <name><surname>Wordsworth</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>A multicentre randomised controlled trial of transfusion indication threshold reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2)</article-title>. <source>Health Technol Assess.</source> (<year>2016</year>) <volume>20</volume>:<fpage>1</fpage>&#x02013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.3310/hta20600</pub-id><pub-id pub-id-type="pmid">27527344</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname> <given-names>B</given-names></name> <name><surname>Giroir</surname> <given-names>B</given-names></name> <name><surname>Randolph</surname> <given-names>A</given-names></name></person-group>. <article-title>International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics</article-title>. <source>Pediatr Crit Care Med.</source> (<year>2005</year>) <volume>6</volume>:<fpage>2</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/01.PCC.0000149131.72248.E6</pub-id><pub-id pub-id-type="pmid">15636651</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schierbauer</surname> <given-names>J</given-names></name> <name><surname>Hoffmeister</surname> <given-names>T</given-names></name> <name><surname>Treff</surname> <given-names>G</given-names></name> <name><surname>Wachsmuth</surname> <given-names>NB</given-names></name> <name><surname>Schmidt</surname> <given-names>WFJ</given-names></name></person-group>. <article-title>Effect of exercise-induced reductions in blood volume on cardiac output and oxygen transport capacity</article-title>. <source>Front Physiol.</source> (<year>2021</year>) <volume>12</volume>:<fpage>679232</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2021.679232</pub-id><pub-id pub-id-type="pmid">34135772</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazine</surname> <given-names>A</given-names></name></person-group>. <article-title>Rached-D&#x00027;Astous S, Ducruet T, Lacroix J, Poirier N, Pediatric acute lung injury and sepsis investigators network. Blood transfusions after pediatric cardiac operations: a north american multicenter prospective study</article-title>. <source>Ann Thorac Surg.</source> (<year>2015</year>) <volume>100</volume>:<fpage>671</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.athoracsur.2015.04.033</pub-id><pub-id pub-id-type="pmid">26141778</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broberg</surname> <given-names>CS</given-names></name> <name><surname>Jayaweera</surname> <given-names>AR</given-names></name> <name><surname>Diller</surname> <given-names>GP</given-names></name> <name><surname>Prasad</surname> <given-names>SK</given-names></name> <name><surname>Thein</surname> <given-names>SL</given-names></name> <name><surname>Bax</surname> <given-names>BE</given-names></name> <etal/></person-group>. <article-title>Seeking optimal relation between oxygen saturation and hemoglobin concentration in adults with cyanosis from congenital heart disease</article-title>. <source>Am J Cardiol.</source> (<year>2011</year>) <volume>107</volume>:<fpage>595</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2010.10.019</pub-id><pub-id pub-id-type="pmid">21295176</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gidding</surname> <given-names>SS</given-names></name> <name><surname>Bessel</surname> <given-names>M</given-names></name> <name><surname>Liao</surname> <given-names>YL</given-names></name></person-group>. <article-title>Determinants of hemoglobin concentration in cyanotic heart disease</article-title>. <source>Pediatr Cardiol.</source> (<year>1990</year>) <volume>11</volume>:<fpage>121</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1007/BF02238840</pub-id><pub-id pub-id-type="pmid">2395739</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Padmanabhan</surname> <given-names>H</given-names></name> <name><surname>Siau</surname> <given-names>K</given-names></name> <name><surname>Curtis</surname> <given-names>J</given-names></name> <name><surname>Ng</surname> <given-names>A</given-names></name> <name><surname>Menon</surname> <given-names>S</given-names></name> <name><surname>Luckraz</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Preoperative anemia and outcomes in cardiovascular surgery: systematic review and meta-analysis</article-title>. <source>Ann Thorac Surg.</source> (<year>2019</year>) <volume>108</volume>:<fpage>1840</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.athoracsur.2019.04.108</pub-id><pub-id pub-id-type="pmid">31233718</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miceli</surname> <given-names>A</given-names></name> <name><surname>Romeo</surname> <given-names>F</given-names></name> <name><surname>Glauber</surname> <given-names>M</given-names></name> <name><surname>de Siena</surname> <given-names>PM</given-names></name> <name><surname>Caputo</surname> <given-names>M</given-names></name> <name><surname>Angelini</surname> <given-names>GD</given-names></name></person-group>. <article-title>Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery</article-title>. <source>J Cardiothorac Surg.</source> (<year>2014</year>) <volume>9</volume>:<fpage>137</fpage>. <pub-id pub-id-type="doi">10.1186/1749-8090-9-137</pub-id><pub-id pub-id-type="pmid">25096231</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menahem</surname> <given-names>S</given-names></name> <name><surname>Sehgal</surname> <given-names>A</given-names></name> <name><surname>Meagher</surname> <given-names>S</given-names></name></person-group>. <article-title>Early detection of significant congenital heart disease: The contribution of fetal cardiac ultrasound and newborn pulse oximetry screening</article-title>. <source>J Paediatr Child Health.</source> (<year>2021</year>) <volume>57</volume>:<fpage>323</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/jpc.15355</pub-id><pub-id pub-id-type="pmid">33529483</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>Y</given-names></name> <name><surname>Mikrou</surname> <given-names>P</given-names></name></person-group>. <article-title>Use of prostaglandins in duct-dependent congenital heart conditions</article-title>. <source>Arch Dis Child Educ Pract Ed.</source> (<year>2018</year>) <volume>103</volume>:<fpage>137</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2017-313654</pub-id><pub-id pub-id-type="pmid">29162633</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gidding</surname> <given-names>SS</given-names></name></person-group>. <article-title>Stockman 3rd JA. Erythropoietin in cyanotic heart disease</article-title>. <source>Am Heart J.</source> (<year>1988</year>) <volume>116</volume>:<fpage>128</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/0002-8703(88)90260-8</pub-id><pub-id pub-id-type="pmid">3394615</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname> <given-names>S</given-names></name> <name><surname>Sharma</surname> <given-names>M</given-names></name> <name><surname>Devgan</surname> <given-names>A</given-names></name> <name><surname>Jatana</surname> <given-names>SK</given-names></name></person-group>. <article-title>Iron deficiency anemia in children with cyanotic congenital heart disease and effect on cyanotic spells</article-title>. <source>Med J Armed Forces India.</source> (<year>2018</year>) <volume>74</volume>:<fpage>235</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.mjafi.2017.07.003</pub-id><pub-id pub-id-type="pmid">30093766</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname> <given-names>MM</given-names></name> <name><surname>Van Remoortel</surname> <given-names>H</given-names></name> <name><surname>Meybohm</surname> <given-names>P</given-names></name> <name><surname>Aranko</surname> <given-names>K</given-names></name> <name><surname>Aubron</surname> <given-names>C</given-names></name> <name><surname>Burger</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Patient blood management: recommendations from the 2018 frankfurt consensus conference</article-title>. <source>JAMA.</source> (<year>2019</year>) <volume>321</volume>:<fpage>983</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2019.0554</pub-id><pub-id pub-id-type="pmid">30860564</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaestner</surname> <given-names>M</given-names></name> <name><surname>Schranz</surname> <given-names>D</given-names></name> <name><surname>Warnecke</surname> <given-names>G</given-names></name> <name><surname>Apitz</surname> <given-names>C</given-names></name> <name><surname>Hansmann</surname> <given-names>G</given-names></name> <name><surname>Miera</surname> <given-names>O</given-names></name></person-group>. <article-title>Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK</article-title>. <source>Heart.</source> (<year>2016</year>) <supplement>102 Suppl</supplement> <volume>2</volume>:<fpage>ii57</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2015-307774</pub-id><pub-id pub-id-type="pmid">27053699</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>SI</given-names></name> <name><surname>Chung</surname> <given-names>WJ</given-names></name> <name><surname>Jung</surname> <given-names>SH</given-names></name> <name><surname>Choi</surname> <given-names>DY</given-names></name></person-group>. <article-title>Effects of inhaled iloprost on congenital heart disease with Eisenmenger syndrome</article-title>. <source>Pediatr Cardiol.</source> (<year>2012</year>) <volume>33</volume>:<fpage>744</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s00246-012-0204-0</pub-id><pub-id pub-id-type="pmid">24012036</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khalil</surname> <given-names>M</given-names></name> <name><surname>Jux</surname> <given-names>C</given-names></name> <name><surname>Rueblinger</surname> <given-names>L</given-names></name> <name><surname>Behrje</surname> <given-names>J</given-names></name> <name><surname>Esmaeili</surname> <given-names>A</given-names></name> <name><surname>Schranz</surname> <given-names>D</given-names></name></person-group>. <article-title>Acute therapy of newborns with critical congenital heart disease</article-title>. <source>Transl Pediatr.</source> (<year>2019</year>) <volume>8</volume>:<fpage>114</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.21037/tp.2019.04.06</pub-id><pub-id pub-id-type="pmid">31161078</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scrimgeour</surname> <given-names>GE</given-names></name> <name><surname>Griksaitis</surname> <given-names>MJ</given-names></name> <name><surname>Pappachan</surname> <given-names>JV</given-names></name> <name><surname>Baldock</surname> <given-names>AJ</given-names></name></person-group>. <article-title>The accuracy of noninvasive peripheral pulse oximetry after palliative cardiac surgery in patients with cyanotic congenital heart disease</article-title>. <source>World J Pediatr Congenit Heart Surg.</source> (<year>2017</year>) <volume>8</volume>:<fpage>32</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1177/2150135116673016</pub-id><pub-id pub-id-type="pmid">28033078</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pace</surname> <given-names>ND</given-names></name> <name><surname>Oster</surname> <given-names>ME</given-names></name> <name><surname>Forestieri</surname> <given-names>NE</given-names></name> <name><surname>Enright</surname> <given-names>D</given-names></name> <name><surname>Knight</surname> <given-names>J</given-names></name> <name><surname>Meyer</surname> <given-names>RE</given-names></name></person-group>. <article-title>Sociodemographic factors and survival of infants with congenital heart defects</article-title>. <source>Pediatrics.</source> (<year>2018</year>) <volume>142</volume>:<fpage>e20180302</fpage>. <pub-id pub-id-type="doi">10.1542/peds.2018-0302</pub-id><pub-id pub-id-type="pmid">30111552</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname> <given-names>L</given-names></name> <name><surname>Su</surname> <given-names>Z</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Hu</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Effect of family socioeconomic status on the prognosis of complex congenital heart disease in children: an observational cohort study from China</article-title>. <source>Lancet Child Adolesc Health.</source> (<year>2018</year>) <volume>2</volume>:<fpage>430</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S2352-4642(18)30100-7</pub-id><pub-id pub-id-type="pmid">30169284</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olariu</surname> <given-names>IC</given-names></name> <name><surname>Popoiu</surname> <given-names>A</given-names></name> <name><surname>Ardelean</surname> <given-names>AM</given-names></name> <name><surname>Isac</surname> <given-names>R</given-names></name> <name><surname>Steflea</surname> <given-names>RM</given-names></name> <name><surname>Olariu</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Challenges in the surgical treatment of atrioventricular septal defect in children with and without down syndrome in Romania-A developing country</article-title>. <source>Front Pediatr.</source> (<year>2021</year>) <volume>9</volume>:<fpage>612644</fpage>. <pub-id pub-id-type="doi">10.3389/fped.2021.612644</pub-id><pub-id pub-id-type="pmid">34307243</pub-id></citation></ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>aaHb</term>
<def><p>age-adjusted lower limit of normal hemoglobin</p></def></def-item>
<def-item><term>CaO<sub>2</sub></term>
<def><p>arterial oxygen content</p></def></def-item>
<def-item><term>CHD</term>
<def><p>congenital heart disease</p></def></def-item>
<def-item><term><italic>CI</italic></term>
<def><p>confidence interval</p></def></def-item>
<def-item><term>Hb</term>
<def><p>hemoglobin</p></def></def-item>
<def-item><term><italic>OR</italic></term>
<def><p>odds ratio</p></def></def-item>
<def-item><term>RACHS-1</term>
<def><p>the Risk Adjustment for Congenital Heart Surgery 1</p></def></def-item>
<def-item><term>SaO<sub>2</sub></term>
<def><p>arterial oxygen saturation</p></def></def-item>
<def-item><term>SpO<sub>2</sub></term>
<def><p>pulse oxygen saturation</p></def></def-item>
<def-item><term>VIF</term>
<def><p>variance inflation factor.</p></def></def-item>
</def-list>
</glossary> 
</back>
</article>